Related Experiment Video
Updated: Aug 9, 2026
08:59
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
Parotid Metastases from Head-Neck Cutaneous Squamous Cell Carcinoma: A Prognostic Stratification
Giulia Togo1, Luca Calabrese2, Giovanni dell'Aversana Orabona3
1Maxillofacial and ENT Surgery Unit, Istituto Nazionale Tumori di Napoli IRCCS "G. Pascale", 80131 Naples, Italy.
Current Oncology (Toronto, Ont.)
|July 27, 2026
Summary
This study suggests using lymph node (LN) and intra-glandular lymph node (IGLN) counts to better stage parotid metastases from head and neck cutaneous squamous cell carcinomas (cSCC). This can guide treatment and follow-up for better patient outcomes.
Area of Science:
- Oncology
- Head and Neck Surgery
- Dermatology
Background:
- Cutaneous squamous cell carcinomas (cSCC) of the head and neck are common.
- Differentiating parotid vs. lateral cervical metastases is crucial due to differing prognoses.
Purpose of the Study:
- To assess parotid metastases distribution and recurrence in cSCC.
- To evaluate the prognostic value of lymph node involvement.
- To identify key histopathological prognostic factors.
Main Methods:
- Retrospective analysis of 61 patients surgically treated for parotid metastases from cSCC.
- Evaluation of geographic distribution, recurrence patterns, lateral cervical lymph node (LN) counts, and intra-glandular lymph node (IGLN) counts.
- Identification of prognostic histopathological factors.
Main Results:
- No significant differences in metastasis distribution or recurrence rates across centers.
- Adjuvant radiotherapy associated with improved Overall Survival (OS) in advanced stages.
- Inflammatory biomarkers and IGLN presence correlated significantly with OS, recurrence, and poor prognosis, especially in N3b stage.
Conclusions:
- LN and IGLN counts can enhance N staging for parotid metastases from cSCC.
- Improved staging can guide treatment strategies and postoperative follow-up.
- Further stratification may optimize management for head and neck cSCC patients.
